Sam Parr & Shaan Puri Discuss Martin Shkreli's Control of 2 Billion Dollar Pharmaceutical Companies
11 Jul 2022 · 0 min

0:17
In a brief conversational clip, Sam Parr (and possibly Shaan Puri) highlights Martin Shkreli’s notoriety as the most hated man in America for dramatically inflating the price of the antiparasitic drug Daraprim from about $13 to over $500 per dose. Parr emphasizes Shkreli’s unapologetic, attention‑seeking attitude—celebrating his ability to set any price he wishes. He also notes that Shkreli controls two publicly traded pharmaceutical companies, each with a market capitalization north of one billion dollars, underscoring the scale of his influence in the pharma industry.










